Intuitive Surgical, Inc. (NASDAQ: ISRG) Stock Competitors & Peer Comparison
See ISRG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ISRG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ISRG | $385.13 | +1.90% | 133.2B | 39.21 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.13% |
| BDX | $184.20 | +0.71% | 51.2B | 14.30 | $13.00 | +2.13% |
| RMD | $227.67 | +2.10% | 33.3B | 21.32 | $10.77 | +1.06% |
| MDLN | $33.50 | +2.78% | 27.2B | 23.53 | $1.36 | N/A |
| WST | $361.98 | +1.91% | 25.7B | 42.93 | $8.50 | +0.24% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $90.53 | +0.79% | 15.6B | 12.69 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.13% |
| BAX | $23.52 | -1.42% | 12.3B | 11.39 | $2.08 | +0.17% |
Stock Comparison
Becton, Dickinson and Company (NYSE: BDXA)
ISRG vs BDXA Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas BDXA's P/E ratio is 45.70. In terms of profitability, ISRG's ROE is +0.18%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, ISRG is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
ISRG vs BDX Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, BDX has a market cap of 51.2B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while BDX trades at $184.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas BDX's P/E ratio is 14.30. In terms of profitability, ISRG's ROE is +0.18%, compared to BDX's ROE of +0.04%. Regarding short-term risk, ISRG is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
ISRG vs RMD Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, RMD has a market cap of 33.3B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while RMD trades at $227.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas RMD's P/E ratio is 21.32. In terms of profitability, ISRG's ROE is +0.18%, compared to RMD's ROE of +0.24%. Regarding short-term risk, ISRG is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
ISRG vs MDLN Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, MDLN has a market cap of 27.2B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while MDLN trades at $33.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas MDLN's P/E ratio is 23.53. In terms of profitability, ISRG's ROE is +0.18%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, ISRG is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
ISRG vs WST Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, WST has a market cap of 25.7B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while WST trades at $361.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas WST's P/E ratio is 42.93. In terms of profitability, ISRG's ROE is +0.18%, compared to WST's ROE of +0.19%. Regarding short-term risk, ISRG is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
ISRG vs HOLX Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas HOLX's P/E ratio is 31.54. In terms of profitability, ISRG's ROE is +0.18%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, ISRG is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
ISRG vs SOLV Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, SOLV has a market cap of 15.6B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while SOLV trades at $90.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas SOLV's P/E ratio is 12.69. In terms of profitability, ISRG's ROE is +0.18%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, ISRG is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
ISRG vs BDXB Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas BDXB's P/E ratio is 7.60. In terms of profitability, ISRG's ROE is +0.18%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, ISRG is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
ISRG vs BAX Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, BAX has a market cap of 12.3B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while BAX trades at $23.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas BAX's P/E ratio is 11.39. In terms of profitability, ISRG's ROE is +0.18%, compared to BAX's ROE of -0.17%. Regarding short-term risk, ISRG is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BAX's competition here
Avantor, Inc. (NYSE: AVTR)
ISRG vs AVTR Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, AVTR has a market cap of 10.4B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while AVTR trades at $15.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas AVTR's P/E ratio is 18.15. In terms of profitability, ISRG's ROE is +0.18%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, ISRG is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AVTR's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
ISRG vs COO Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, COO has a market cap of 10.4B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while COO trades at $54.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas COO's P/E ratio is 11.68. In terms of profitability, ISRG's ROE is +0.18%, compared to COO's ROE of +0.07%. Regarding short-term risk, ISRG is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
ISRG vs RGEN Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, RGEN has a market cap of 9.9B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while RGEN trades at $174.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas RGEN's P/E ratio is 97.07. In terms of profitability, ISRG's ROE is +0.18%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, ISRG is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
ISRG vs ATR Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, ATR has a market cap of 8B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while ATR trades at $125.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas ATR's P/E ratio is 21.79. In terms of profitability, ISRG's ROE is +0.18%, compared to ATR's ROE of +0.14%. Regarding short-term risk, ISRG is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
ISRG vs BLCO Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while BLCO trades at $17.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas BLCO's P/E ratio is 26.52. In terms of profitability, ISRG's ROE is +0.18%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, ISRG is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
ISRG vs STVN Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, STVN has a market cap of 5.9B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while STVN trades at $21.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas STVN's P/E ratio is 32.57. In terms of profitability, ISRG's ROE is +0.18%, compared to STVN's ROE of +0.09%. Regarding short-term risk, ISRG is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check STVN's competition here
Teleflex Incorporated (NYSE: TFX)
ISRG vs TFX Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, TFX has a market cap of 5.7B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while TFX trades at $129.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas TFX's P/E ratio is 14.75. In terms of profitability, ISRG's ROE is +0.18%, compared to TFX's ROE of -0.32%. Regarding short-term risk, ISRG is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
ISRG vs MMSI Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, MMSI has a market cap of 5.1B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while MMSI trades at $86.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas MMSI's P/E ratio is 22.04. In terms of profitability, ISRG's ROE is +0.18%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, ISRG is less volatile compared to MMSI. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check MMSI's competition here
Envista Holdings Corp (NYSE: NVST)
ISRG vs NVST Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, NVST has a market cap of 4B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while NVST trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas NVST's P/E ratio is 16.85. In terms of profitability, ISRG's ROE is +0.18%, compared to NVST's ROE of +0.04%. Regarding short-term risk, ISRG is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check NVST's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
ISRG vs ICUI Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while ICUI trades at $158.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas ICUI's P/E ratio is 19.46. In terms of profitability, ISRG's ROE is +0.18%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, ISRG is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
ISRG vs PLSE Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while PLSE trades at $49.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas PLSE's P/E ratio is -46.78. In terms of profitability, ISRG's ROE is +0.18%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, ISRG is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
ISRG vs ATRC Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while ATRC trades at $56.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas ATRC's P/E ratio is 1745.96. In terms of profitability, ISRG's ROE is +0.18%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, ISRG is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
ISRG vs XRAY Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, XRAY has a market cap of 2B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while XRAY trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas XRAY's P/E ratio is 6.87. In terms of profitability, ISRG's ROE is +0.18%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, ISRG is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
ISRG vs LMAT Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while LMAT trades at $80.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas LMAT's P/E ratio is 29.69. In terms of profitability, ISRG's ROE is +0.18%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, ISRG is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
ISRG vs BLFS Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while BLFS trades at $36.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas BLFS's P/E ratio is -172.18. In terms of profitability, ISRG's ROE is +0.18%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, ISRG is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
ISRG vs AZTA Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while AZTA trades at $33.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas AZTA's P/E ratio is 78.64. In terms of profitability, ISRG's ROE is +0.18%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, ISRG is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
ISRG vs KMTS Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, KMTS has a market cap of 1.5B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while KMTS trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas KMTS's P/E ratio is -9.50. In terms of profitability, ISRG's ROE is +0.18%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, ISRG is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
ISRG vs STAA Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, STAA has a market cap of 1.1B. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while STAA trades at $22.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas STAA's P/E ratio is 39.38. In terms of profitability, ISRG's ROE is +0.18%, compared to STAA's ROE of +0.01%. Regarding short-term risk, ISRG is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
ISRG vs ATRI Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas ATRI's P/E ratio is 64.50. In terms of profitability, ISRG's ROE is +0.18%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, ISRG is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
ISRG vs ANGO Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, ANGO has a market cap of 648.1M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while ANGO trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas ANGO's P/E ratio is -40.21. In terms of profitability, ISRG's ROE is +0.18%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, ISRG is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ANGO's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
ISRG vs SMTI Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, SMTI has a market cap of 322.8M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while SMTI trades at $35.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas SMTI's P/E ratio is -585.17. In terms of profitability, ISRG's ROE is +0.18%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, ISRG is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SMTI's competition here
Embecta Corp. (NASDAQ: EMBC)
ISRG vs EMBC Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, EMBC has a market cap of 302M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while EMBC trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas EMBC's P/E ratio is 1.96. In terms of profitability, ISRG's ROE is +0.18%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, ISRG is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check EMBC's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
ISRG vs NNNN Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, NNNN has a market cap of 241.8M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while NNNN trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas NNNN's P/E ratio is 79.62. In terms of profitability, ISRG's ROE is +0.18%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, ISRG is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
ISRG vs OSUR Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, OSUR has a market cap of 238.2M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while OSUR trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas OSUR's P/E ratio is -5.01. In terms of profitability, ISRG's ROE is +0.18%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, ISRG is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
ISRG vs UTMD Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, UTMD has a market cap of 237.6M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while UTMD trades at $74.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas UTMD's P/E ratio is 22.08. In terms of profitability, ISRG's ROE is +0.18%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, ISRG is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
ISRG vs PDEX Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, PDEX has a market cap of 213.6M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while PDEX trades at $72.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas PDEX's P/E ratio is 16.20. In terms of profitability, ISRG's ROE is +0.18%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, ISRG is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
ISRG vs KRMD Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, KRMD has a market cap of 145.1M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while KRMD trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas KRMD's P/E ratio is -79.00. In terms of profitability, ISRG's ROE is +0.18%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, ISRG is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
ISRG vs STXS Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, STXS has a market cap of 129.3M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while STXS trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas STXS's P/E ratio is -7.76. In terms of profitability, ISRG's ROE is +0.18%, compared to STXS's ROE of -1.33%. Regarding short-term risk, ISRG is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check STXS's competition here
Daxor Corporation (NASDAQ: DXR)
ISRG vs DXR Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, DXR has a market cap of 68M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while DXR trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas DXR's P/E ratio is 9.47. In terms of profitability, ISRG's ROE is +0.18%, compared to DXR's ROE of +0.13%. Regarding short-term risk, ISRG is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check DXR's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
ISRG vs AKYA Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas AKYA's P/E ratio is -1.34. In terms of profitability, ISRG's ROE is +0.18%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, ISRG is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
ISRG vs STSS Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas STSS's P/E ratio is -0.02. In terms of profitability, ISRG's ROE is +0.18%, compared to STSS's ROE of -1.54%. Regarding short-term risk, ISRG is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
ISRG vs OMIC Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas OMIC's P/E ratio is -0.58. In terms of profitability, ISRG's ROE is +0.18%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, ISRG is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
ISRG vs IGAP Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas IGAP's P/E ratio is -10.52. In terms of profitability, ISRG's ROE is +0.18%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, ISRG is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
ISRG vs NEPH Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, NEPH has a market cap of 46.6M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while NEPH trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas NEPH's P/E ratio is 71.50. In terms of profitability, ISRG's ROE is +0.18%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, ISRG is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
ISRG vs POCI Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, POCI has a market cap of 46.1M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while POCI trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas POCI's P/E ratio is -6.68. In terms of profitability, ISRG's ROE is +0.18%, compared to POCI's ROE of -0.37%. Regarding short-term risk, ISRG is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check POCI's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
ISRG vs HBIO Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, HBIO has a market cap of 36M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while HBIO trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas HBIO's P/E ratio is -22.17. In terms of profitability, ISRG's ROE is +0.18%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, ISRG is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check HBIO's competition here
Milestone Scientific Inc. (AMEX: MLSS)
ISRG vs MLSS Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, MLSS has a market cap of 35.5M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while MLSS trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas MLSS's P/E ratio is -8.02. In terms of profitability, ISRG's ROE is +0.18%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, ISRG is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check MLSS's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
ISRG vs SDC Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas SDC's P/E ratio is -0.03. In terms of profitability, ISRG's ROE is +0.18%, compared to SDC's ROE of -1.96%. Regarding short-term risk, ISRG is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
ISRG vs IVC Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas IVC's P/E ratio is -0.79. In terms of profitability, ISRG's ROE is +0.18%, compared to IVC's ROE of -0.46%. Regarding short-term risk, ISRG is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
ISRG vs RVP Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while RVP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas RVP's P/E ratio is -5.67. In terms of profitability, ISRG's ROE is +0.18%, compared to RVP's ROE of -0.05%. Regarding short-term risk, ISRG is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
ISRG vs BNGO Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, BNGO has a market cap of 17.9M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while BNGO trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas BNGO's P/E ratio is -0.36. In terms of profitability, ISRG's ROE is +0.18%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, ISRG is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check BNGO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
ISRG vs ZJYL Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, ZJYL has a market cap of 15.6M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while ZJYL trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas ZJYL's P/E ratio is 13.61. In terms of profitability, ISRG's ROE is +0.18%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, ISRG is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check ZJYL's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
ISRG vs RGNT Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, RGNT has a market cap of 12.6M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while RGNT trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas RGNT's P/E ratio is -0.07. In terms of profitability, ISRG's ROE is +0.18%, compared to RGNT's ROE of N/A. Regarding short-term risk, ISRG is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check RGNT's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
ISRG vs CUPR Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, CUPR has a market cap of 7.9M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while CUPR trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas CUPR's P/E ratio is -2.12. In terms of profitability, ISRG's ROE is +0.18%, compared to CUPR's ROE of -15.69%. Regarding short-term risk, ISRG is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check CUPR's competition here
Femasys Inc. (NASDAQ: FEMY)
ISRG vs FEMY Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, FEMY has a market cap of 7.7M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while FEMY trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas FEMY's P/E ratio is -0.57. In terms of profitability, ISRG's ROE is +0.18%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, ISRG is more volatile compared to FEMY. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check FEMY's competition here
Lucyd, Inc (NASDAQ: LUCY)
ISRG vs LUCY Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, LUCY has a market cap of 5.2M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while LUCY trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas LUCY's P/E ratio is -0.49. In terms of profitability, ISRG's ROE is +0.18%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, ISRG is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
ISRG vs NSTG Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas NSTG's P/E ratio is -0.03. In terms of profitability, ISRG's ROE is +0.18%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, ISRG is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NSTG's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
ISRG vs POAI Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas POAI's P/E ratio is -0.03. In terms of profitability, ISRG's ROE is +0.18%, compared to POAI's ROE of -21.19%. Regarding short-term risk, ISRG is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
ISRG vs MHUA Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas MHUA's P/E ratio is 0.25. In terms of profitability, ISRG's ROE is +0.18%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, ISRG is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
ISRG vs NXGL Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, NXGL has a market cap of 2.4M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while NXGL trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas NXGL's P/E ratio is -0.40. In terms of profitability, ISRG's ROE is +0.18%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, ISRG is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
ISRG vs GMVD Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas GMVD's P/E ratio is -0.01. In terms of profitability, ISRG's ROE is +0.18%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, ISRG is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
ISRG vs GMVDW Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas GMVDW's P/E ratio is N/A. In terms of profitability, ISRG's ROE is +0.18%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, ISRG is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
ISRG vs AVGR Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas AVGR's P/E ratio is -0.05. In terms of profitability, ISRG's ROE is +0.18%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, ISRG is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
ISRG vs NXGLW Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, NXGLW has a market cap of 1.2M. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, ISRG's ROE is +0.18%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, ISRG is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
ISRG vs LUCYW Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas LUCYW's P/E ratio is N/A. In terms of profitability, ISRG's ROE is +0.18%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, ISRG is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check LUCYW's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
ISRG vs HRC Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, HRC has a market cap of 0. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas HRC's P/E ratio is 41.92. In terms of profitability, ISRG's ROE is +0.18%, compared to HRC's ROE of +0.14%. Regarding short-term risk, ISRG is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check HRC's competition here
IntriCon Corporation (NASDAQ: IIN)
ISRG vs IIN Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, IIN has a market cap of 0. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas IIN's P/E ratio is 226.45. In terms of profitability, ISRG's ROE is +0.18%, compared to IIN's ROE of -0.00%. Regarding short-term risk, ISRG is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
ISRG vs ALOG Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas ALOG's P/E ratio is 40.93. In terms of profitability, ISRG's ROE is +0.18%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, ISRG is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ALOG's competition here
Apria, Inc. (NASDAQ: APR)
ISRG vs APR Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, APR has a market cap of 0. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas APR's P/E ratio is 22.59. In terms of profitability, ISRG's ROE is +0.18%, compared to APR's ROE of +9.81%. Regarding short-term risk, ISRG is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check APR's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
ISRG vs ATRS Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas ATRS's P/E ratio is 14.95. In terms of profitability, ISRG's ROE is +0.18%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, ISRG is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
ISRG vs IVTY Comparison September 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 133.2B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, ISRG is priced at $385.13 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 39.21, whereas IVTY's P/E ratio is -3.80. In terms of profitability, ISRG's ROE is +0.18%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, ISRG is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check IVTY's competition here